Literature DB >> 7731025

The synthesis of N-hydroxy-N'-phenyloctanediamide and its inhibitory effect on proliferation of AXC rat prostate cancer cells.

J C Stowell1, R I Huot, L Van Voast.   

Abstract

We have developed a practical synthesis of N-hydroxy-N'-phenyloctanediamide from the methyl ester of suberanilic acid. It provides the product in high yield and purity with a simple purification process. We have found that at 10(-5) M it has a dramatic effect on T/5 AXC/SSh rat prostate cancer cells in vitro. It is a potent inhibitor of cell proliferation and it changes the cell morphology to resemble nonmalignant cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731025     DOI: 10.1021/jm00008a020

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

Review 1.  Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.

Authors:  Zhiyan Xiao; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2015-09-11       Impact factor: 12.944

2.  Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

Authors:  V M Richon; Y Webb; R Merger; T Sheppard; B Jursic; L Ngo; F Civoli; R Breslow; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats.

Authors:  Abishek Iyer; Andrew Fenning; Junxian Lim; Giang T Le; Robert C Reid; Maria A Halili; David P Fairlie; Lindsay Brown
Journal:  Br J Pharmacol       Date:  2010-02-24       Impact factor: 8.739

4.  Synergistic induction of apoptosis in brain cancer cells by targeted codelivery of siRNA and anticancer drugs.

Authors:  Cheoljin Kim; Birju P Shah; Prasad Subramaniam; Ki-Bum Lee
Journal:  Mol Pharm       Date:  2011-08-05       Impact factor: 4.939

5.  Monitoring Tumor Response After Histone Deacetylase Inhibitor Treatment Using 3'-Deoxy-3'-[18F]-fluorothymidine PET.

Authors:  Pei-Chia Chan; Chun-Yi Wu; Lin-Shan Chou; Chung-Hsien Ho; Chi-Wei Chang; Shih-Hwa Chiou; Wuu-Jyh Lin; Fu-Du Chen; C Allen Chang; Jeng-Jong Hwang; Ren-Shyan Liu; Hsin-Ell Wang
Journal:  Mol Imaging Biol       Date:  2015-06       Impact factor: 3.488

6.  2-Hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease.

Authors:  Jessica Davidson; Elizabeth Molitor; Samantha Moores; Sarah E Gale; Kanagaraj Subramanian; Xuntian Jiang; Rohini Sidhu; Pamela Kell; Jesse Zhang; Hideji Fujiwara; Cristin Davidson; Paul Helquist; Bruce J Melancon; Michael Grigalunas; Gang Liu; Farbod Salahi; Olaf Wiest; Xin Xu; Forbes D Porter; Nina H Pipalia; Dana L Cruz; Edward B Holson; Jean E Schaffer; Steven U Walkley; Frederick R Maxfield; Daniel S Ory
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-04-30       Impact factor: 4.698

7.  A new amidohydrolase from Bordetella or Alcaligenes strain FB188 with similarities to histone deacetylases.

Authors:  Christian Hildmann; Milena Ninkovic; Rüdiger Dietrich; Dennis Wegener; Daniel Riester; Thomas Zimmermann; Olwen M Birch; Christine Bernegger; Peter Loidl; Andreas Schwienhorst
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

8.  Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretion.

Authors:  Erica Dresselhaus; James M Duerr; Fabien Vincent; Emily K Sylvain; Mercedes Beyna; Lorraine F Lanyon; Erik LaChapelle; Martin Pettersson; Kelly R Bales; Gayathri Ramaswamy
Journal:  PLoS One       Date:  2018-03-26       Impact factor: 3.240

9.  A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests.

Authors:  Frederick A Schroeder; Michael C Lewis; Daniel M Fass; Florence F Wagner; Yan-Ling Zhang; Krista M Hennig; Jennifer Gale; Wen-Ning Zhao; Surya Reis; Douglas D Barker; Erin Berry-Scott; Sung Won Kim; Elizabeth L Clore; Jacob M Hooker; Edward B Holson; Stephen J Haggarty; Tracey L Petryshen
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

10.  Histone deacetylases control neurogenesis in embryonic brain by inhibition of BMP2/4 signaling.

Authors:  Maya Shakèd; Kathrin Weissmüller; Hanno Svoboda; Peter Hortschansky; Norikazu Nishino; Stefan Wölfl; Kerry L Tucker
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.